🇺🇸 FDA
Patent

US 9809604

DGAT1 inhibitor and preparation method and use thereof

granted A61KA61K31/553A61P

Quick answer

US patent 9809604 (DGAT1 inhibitor and preparation method and use thereof) held by Medshine Discovery Inc. expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/553, A61P, A61P3/04, A61P3/06